Analytical Goals for Point-of-Care Testing Used for Diabetes Management in Australian Health Care Settings Outside The Laboratory

摘要: Diabetes mellitus is a major global health problem. Pathology testing for hemoglobin A1c (HbA1c), lipids, and urine albumin/creatinine ratio (ACR) has an important role in the management of diabetes patients. Each these markers can be performed by point-of-care (POCT). This article focuses on setting analytical goals (quality specifications) imprecision, bias, total allowable error selected POC tests public environment Australia. The reviews published data goal laboratory tests, considers factors that set POCT apart from laboratory, compares laboratory-based with state-of-the-art performance, then sets are designed to relevant nonlaboratory environment. desirable imprecision following: HbA1c, 3%; cholesterol, triglyceride, 5%; high-density lipoprotein choles- terol, 4%; low-density albumin, 10%; creatinine, 6%; ACR, 12%. 15%; 12.5%; 7.5%; 15%. recommended flexible refinable as more data, particularly clinical outcome studies, become available. They have potential adopted countries outside Australia, given limited specifically sector.